Mode
Text Size
Log in / Sign up

Rheumatoid Arthritis

Part of Arthritis

Subtypes of Rheumatoid Arthritis

Acute exacerbation of rheumatoid arthritis–associated interstitial lung disease 1 Elderly-onset rheumatoid arthritis 1

87 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Rheumatoid Arthritis

781 trials tracked for Rheumatoid Arthritis: 364 in phase 3 or 4 and 141 with published results. The most-cited published study has 394 citations.

781Trials tracked
364Phase 3 & 4
0Recruiting
141With published results
Phase distribution
Phase 4 95 Phase 3 269 Phase 2 161 Phase 1 39 Other / NA 217
  1. Phase 3 Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis Completed · 394 cited
  2. Phase 3 Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment Completed · 326 cited
  3. Phase 3 Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis Completed · 299 cited
  4. Phase 3 Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis Completed · 282 cited
  5. Phase 3 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Completed · 269 cited
  6. Phase 3 A Moderate to Severe Rheumatoid Arthritis Study Completed · 258 cited
Show 44 more trials
  1. Phase 4 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Completed · 230 cited
  2. Phase 3 A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy Completed · 229 cited
  3. Phase 3 Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Completed · 216 cited
  4. Phase 3 Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis Completed · 215 cited
  5. Phase 3 To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) Completed · 209 cited
  6. Phase 3 Efficacy Study Of Tofacitinib In Pediatric JIA Population Completed · 187 cited
  7. Phase 3 Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis Completed · 186 cited
  8. Phase 3 Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) Completed · 180 cited
  9. Phase 4 Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate Completed · 179 cited
  10. Phase 3 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis Completed · 167 cited
  11. Phase 3 A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy Completed · 166 cited
  12. Phase 4 The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Completed · 159 cited
  13. Phase 3 A Study in Moderate to Severe Rheumatoid Arthritis Participants Completed · 158 cited
  14. Phase 3 A Study in Moderate to Severe Rheumatoid Arthritis Completed · 158 cited
  15. Phase 3 A Study in Participants With Moderate to Severe Rheumatoid Arthritis Completed · 158 cited
  16. Phase 3 A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) Completed · 158 cited
  17. Phase 3 An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Completed · 158 cited
  18. Phase 4 Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis Completed · 157 cited
  19. Phase 3 A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis Completed · 157 cited
  20. Phase 4 MTX Discontinuation and Vaccine Response Completed · 138 cited
  21. Phase 3 A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy Completed · 133 cited
  22. Phase 3 A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment Completed · 129 cited
  23. Phase 4 Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. Completed · 128 cited
  24. Phase 4 Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants Completed · 125 cited
  25. Phase 3 To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) Completed · 124 cited
  26. Phase 3 Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis Completed · 116 cited
  27. Phase 4 COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA Completed · 114 cited
  28. Phase 3 A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs Completed · 108 cited
  29. Phase 3 A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Completed · 108 cited
  30. Phase 3 A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy Completed · 105 cited
  31. Phase 3 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis Completed · 99 cited
  32. Phase 3 Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis Completed · 88 cited
  33. Phase 3 Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease Completed · 79 cited
  34. Phase 3 A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis Completed · 77 cited
  35. Phase 3 Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA) Completed · 75 cited
  36. Phase 4 Treatments Against RA and Effect on FDG-PET/CT Completed · 73 cited
  37. Phase 3 Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease Completed · 72 cited
  38. Phase 3 PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease Completed · 71 cited
  39. Phase 4 IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA Completed · 70 cited
  40. Phase 3 Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Completed · 70 cited
  41. Phase 3 A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) Completed · 66 cited
  42. Phase 3 A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs Completed · 64 cited
  43. Phase 3 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Completed · 62 cited
  44. Phase 3 A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). Completed · 59 cited

Showing the 50 most-cited and recently-updated of 781 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Arthritis

Related studies from across the Arthritis family.

Review of ruxolitinib for systemic juvenile arthritis with macrophage activation syndrome
Pediatrics Sys. Review
Review of ruxolitinib for systemic juvenile arthritis with macrophage activation syndrome Two children with severe arthritis found relief using a new drug approach
This narrative review synthesizes a retrospective case series and literature search on ruxolitinib for systemic juvenile idiopathic arthriti…
Two children with severe arthritis complications found relief using a new drug approach, offering hope for those who struggle with standard …
Telephone-delivered Walk With Ease program recruitment strategies compared in adults with arthritis
Primary Care & Family Medicine RCT
Telephone-delivered Walk With Ease program recruitment strategies compared in adults with arthritis Radio ads and Facebook work best to recruit arthritis patients
This randomized trial in 267 adults with arthritis compared recruitment strategies for a telephone-delivered walking program. Facebook was t…
Radio ads and Facebook ads work best to get arthritis patients into walking programs, but the best method depends on who you are trying to r…
Ixekizumab shows efficacy in children with enthesitis-related and juvenile psoriatic arthritis
Dermatology RCT
Ixekizumab shows efficacy in children with enthesitis-related and juvenile psoriatic arthritis New drug ixekizumab shows promise for children with arthritis
This multicentre, open-label, phase 3 study evaluated ixekizumab in 101 children with enthesitis-related arthritis or juvenile psoriatic art…
A phase 3 study found ixekizumab helped many children with arthritis meet response criteria at week 16, with mostly mild side effects report…
Systematic review and meta-analysis supports adalimumab plus methotrexate for JIA-associated uveitis
Pediatrics Meta-analysis
Systematic review and meta-analysis supports adalimumab plus methotrexate for JIA-associated uveitis Combination therapy reduces relapse risk in children with eye inflammation from arthritis
This systematic review and meta-analysis of RCTs evaluated adalimumab plus methotrexate in children with juvenile idiopathic arthritis-assoc…
Combining adalimumab with methotrexate lowers relapse risk and helps reduce steroid use in children with arthritis-related eye inflammation.
Baricitinib showed limited efficacy in pediatric JIA-uveitis patients refractory to methotrexate or biologics at week 24
Drug Pipeline RCT
Baricitinib showed limited efficacy in pediatric JIA-uveitis patients refractory to methotrexate or biologics at week 24 New Hope for Kids with Stubborn Eye Inflammation
This open-label, active-controlled phase-3 multicenter trial enrolled 30 pediatric patients with juvenile idiopathic arthritis-associated uv…
A new drug shows early promise for children with stubborn eye inflammation who didn't respond to standard treatments, offering hope when oth…

Questions about Rheumatoid Arthritis

Did baricitinib work well for juvenile idiopathic arthritis eye inflammation?

Baricitinib showed limited effectiveness for treating eye inflammation in children with juvenile idiopathic arthritis who did not respond to other standard treatments.

Full answer →
Can machine learning predict when juvenile idiopathic arthritis will go inactive?

Yes, machine learning models using registry data can predict inactive disease in juvenile idiopathic arthritis with about 70-76% accuracy, but they are not yet ready for routine clinical use.

Full answer →
Can Hadlima be used to treat juvenile idiopathic arthritis?

Yes, Hadlima (adalimumab) is FDA-approved to treat moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 2 years and older.

Full answer →
How does macrophage metabolism change in gouty arthritis patients?

In gouty arthritis, macrophages shift their energy use from oxidative phosphorylation to glycolysis and change from pro-inflammatory to anti-inflammatory states as the attack resolves.

Full answer →
Does quercetin work for gouty arthritis based on recent reviews?

Recent reviews suggest quercetin has anti-inflammatory and antioxidant properties that could help with gout, but there is currently no strong clinical proof it works for gouty arthritis in humans.

Full answer →
Why do current gouty arthritis models fail to match human disease?

Current gout models fail because they do not fully capture the complex metabolic changes in macrophages or the chronic, multi-factorial nature of human disease.

Full answer →
How is Arthritis Awareness Month observed to highlight the condition's impact?

Arthritis Awareness Month is observed in May to bring attention to the condition and its impact on daily life.

Full answer →
What percentage of U.S. adults with arthritis engage in physical activity?

About 67% of U.S. adults with arthritis engage in at least one type of physical activity, though many do not meet full health guidelines.

Full answer →
See all 21 questions about Rheumatoid Arthritis →

All Rheumatoid Arthritis Articles